Begor Mark W 4

Accession 0001225208-25-008793

CIK 0000033185other

View on SEC.gov Company Profile

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 4:09 PM ET

Size

38.2 KB

Accession

0001225208-25-008793

Insider Transaction Report

Form 4

Period: 2025-10-27

EQUIFAX INCEFX

Begor Mark W

DirectorCEO

Transactions

Sale
Common Stock
2025-10-27$233.95/sh−37$8,656→ 43,394 total(indirect: 2-yr Jun 2025 GRAT)
Sale
Common Stock
2025-10-27$231.59/sh−3,331$771,439→ 37,186 total(indirect: 2-yr Jun 2025 GRAT)
Sale
Common Stock
2025-10-27$230.18/sh−6,639$1,528,192→ 149,877 total
Exercise/Conversion
Common Stock
2025-10-27$191.44/sh+27,959$5,352,471→ 170,940 total
Sale
Common Stock
2025-10-27$233.88/sh−174$40,694→ 170,719 total
Sale
Common Stock
2025-10-27$235.22/sh−204$47,985→ 170,515 total
Sale
Common Stock
2025-10-27$231.46/sh−3,757$869,590→ 166,758 total
Sale
Common Stock
2025-10-27$229.20/sh−6,227$1,427,255→ 156,516 total
Sale
Common Stock
2025-10-27$232.19/sh−6,943$1,612,086→ 142,934 total
Sale
Common Stock
2025-10-27$229.12/sh−3,995$915,337→ 33,191 total(indirect: 2-yr Jun 2025 GRAT)
Gift
Common Stock
2025-10-27−47→ 170,893 total
Sale
Common Stock
2025-10-27$230.16/sh−5,872$1,351,500→ 22,045 total(indirect: 2-yr Jun 2025 GRAT)
Exercise/Conversion
Stock Option/Right to Buy
2025-10-27−27,959→ 0 total
Exercise: $191.44Exp: 2026-02-21→ Common Stock (27,959 underlying)
Sale
Common Stock
2025-10-27$233.01/sh−4,015$935,549→ 162,743 total
Sale
Common Stock
2025-10-27$234.93/sh−76$17,855→ 43,318 total(indirect: 2-yr Jun 2025 GRAT)
Sale
Common Stock
2025-10-27$233.12/sh−2,801$652,979→ 40,517 total(indirect: 2-yr Jun 2025 GRAT)
Sale
Common Stock
2025-10-27$232.27/sh−5,274$1,224,994→ 27,917 total(indirect: 2-yr Jun 2025 GRAT)

Holdings

Common Stock
(indirect: 2-yr Jul 2024 GRAT)
11,380
Common Stock
(indirect: 2-yr May 2025 GRAT)
12,333
Common Stock
(indirect: 3-yr Jul 2024 GRAT)
16,287
Common Stock
(indirect: 2-yr 2025 GRAT)
10,500
Common Stock
(indirect: 2-yr Feb 2024 GRAT)
9,525

Footnotes (16)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.
[F10]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.88 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F11]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.85 to $233.80, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F12]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.83 to $231.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F13]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.685, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F14]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.845 to $232.81, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F15]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.7507 to $230.7266, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F16]The option vested in three equal annual increments beginning 2/21/2021.
[F2]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
[F3]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.795 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F4]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $234.93 to $235.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F5]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.74 to $231.734, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F6]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.74 to $233.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F7]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F8]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.74 to $230.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F9]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.735 to $232.71, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Documents

1 file

4
doc4.xmlPrimary

Issuer

EQUIFAX INC

CIK 0000033185

→

Entity typeother

Related Parties

filerCIK 0001335111

Filing Metadata

Form type: 4
Filed: Oct 28, 8:00 PM ET
Accepted: Oct 29, 4:09 PM ET
Size: 38.2 KB

View on SEC.gov